We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lipoxen | LSE:LPX | London | Ordinary Share | GB00B08NWV55 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.875 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/4/2011 00:58 | Yes, it could be huge, but that's years down the road, and judging by the market's reaction, I'd say investors want to know what's going to pay Lipoxen's rent in the more immediate future. | 123asd | |
07/4/2011 00:24 | This by itself could be a 'game changer' for Lipoxen IAVI collaboration update Share this article TIDMLPX RNS Number : 2839E Lipoxen PLC 05 April 2011 5 April 2011 Lipoxen plc ('Lipoxen' or the 'Company') IAVI collaboration update Lipoxen (AIM: LPX.L), a bio-pharmaceutical company specialising in the development of high-value differentiated biological, vaccines and siRNA delivery, announces that is has agreed an extension of the existing research agreement with the International Aids Vaccine Initiative (IAVI), the world's leading AIDS vaccine organization. Based on data generated during the research phase of the original agreement, Lipoxen and IAVI have identified a vaccine formulation that, when used in a relevant preclinical model, induced antibodies which subsequently neutralised a number of different HIV strains when tested in the laboratory. IAVI have extended the agreement which will now run until 30 September 2011. This will allow Lipoxen to create advanced versions of the candidate formulation and IAVI to undertake a repeat of the immunisation study to assess the efficacy of the refined vaccine. Subject to the final results, Lipoxen and IAVI will jointly negotiate terms for the further development of any promising vaccine candidate. Commenting on the extension, M. Scott Maguire, Chief Executive Officer of Lipoxen, said: "The extension is a positive step and reflects the good antibody responses to our formulations. With more than 7,100 people a day infected with HIV there is strong demand for safe and effective vaccines for HIV and we hope that the extension will help us and IAVI take a step closer to developing a refined vaccine formulation that meets this need." | buywell2 | |
05/4/2011 19:31 | Thanks for posting. "could be huge" - let's hope investors think so! | keeshond | |
05/4/2011 10:07 | Very promising news - could be huge. | drewz | |
05/4/2011 09:53 | Apologies if already seen ... ATB Weevie | weevie1978 | |
23/3/2011 07:17 | prelimanary results were on the 1st of april last year... | bobdown2 | |
21/3/2011 22:48 | Nice triangle formation building on the LPX chart Supports move to 20p on good RNS news Like signing up with a western partner for example re previous RNS testing results | buywell2 | |
21/3/2011 14:00 | Hopefully some news at last! | ak123 | |
21/3/2011 13:37 | onward and upward! | jsbach123 | |
18/3/2011 22:58 | Could be some contracts to be won with Japanese companies at this time | buywell2 | |
18/3/2011 22:53 | Looks like your post turned the stock back up again Moving averages still look good. Positive RNS news could send the stock back up to 20p dyor | buywell2 | |
18/3/2011 14:49 | I bought some yesterday as they looked cheap given the earlier news a few months ago. I think they're just catching up.Everybody should have a few of these I reckon. | ohisay | |
18/3/2011 10:22 | spoke to soon....jumped up today..is there anything to this or had thjey just fallen to far.. | bobdown2 | |
17/3/2011 20:46 | amonth since a post...a forgoton biotech...just giving it a post as it must be getting an inferiority complex..think you must try harder to get an rns out, | bobdown2 | |
16/2/2011 16:19 | I think the interview took place some time ago but is still available on the website of ProactiveInvestors.c | richardwong78 | |
16/2/2011 16:07 | richardwong78....... | duplicate book | |
16/2/2011 16:00 | thanks rw78. maybe said interview itself has created a bit of todays interest. | bobdown2 | |
16/2/2011 15:57 | Two Wongs don't make it right :o)) | duplicate book | |
16/2/2011 15:55 | The bull point from a charting perspective is that not only is the share price in an up trend it is also above the short-term and long-term moving averages. The company is also fundamentally sound. After listening to the CEO's interview with Proactive Investors yesterday I could not resist in investing in this company. | richardwong78 | |
16/2/2011 15:24 | I hope you are right, Mr Wong. | drewz | |
16/2/2011 15:21 | If you look at the chart the share price is at the beginning of a breakout. I expect it to go up to at least 20p. | richardwong78 | |
16/2/2011 13:36 | whoops. another tick up. | bobdown2 | |
16/2/2011 13:32 | some slightly larger buys than of late going through. will have to watch for an increase in activity. | bobdown2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions